Abstract Objective Temporomandibular disorders (TMDs) encompass several conditions that
cause pain and impair function of the masticatory muscles (M-TMDs) and …

Background Botulinum toxin type A (BTX‐A) is increasingly used to manage painful
temporomandibular disorders (TMD). However, the effect of BTX‐A on muscular TMD …

The antinociceptive effect of BoNT-A have been well documented in animal studies;
however, results of few but well-designed randomized placebo-controlled clinical trials …

Temporomandibular disorders include various conditions that impact the masticatory
system, affecting its structure, function, or physiology. Clinicians face a complex array of …

Background: Several studies have considered Botulinum Neurotoxin Type A injections
effective in treating temporomandibular joint disorder (TMD) symptoms. A double-blind …

Botulinum toxin type A (BTA) is applied in muscle hyperactivity disorders and injected into
affected muscles, producing deep and persistent muscle relaxation. Several …

Abstract Background The Herbst appliance is an excellent therapy for treating class II
malocclusions with increased overjet. Its mechanics involve propelling the mandibular bone …

Background: The reduction in joint load is a potential beneficial factor in managing
osteoarthritis of the temporomandibular joint (TMJ). This paper aims to compare the …

Chronic pain affects up to 40% of adults, contributing to high medical expenses, the loss of
productivity, reduced quality of life (QoL), and disability. Chronic pain requires detailed …

Patients who suffer from myofascial orofacial pain could affect their quality of life deeply. The
pathogenesis of pain is still unclear. Our objective was to assess Whether Voltage-gated …